While full details of the deal are being kept confidential, notably the name of the pharma firm involved, PDI did disclose that it would be based around its Shared Sales model and that the campaign will begin next month.
PDI CEO Nancy Lurker said: “This new engagement, coupled with other significant new contracts secured in 2009, allows us to enter 2010 with confidence and optimism."
